Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Stantec Inc is an engineering & construction business based in the US. Stantec shares (STN) are listed on the NYSE and all prices are listed in US Dollars. Stantec employs 25,000 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $44.08 |
|---|---|
| 52-week range | $40.79 - $58.01 |
| 50-day moving average | $44.71 |
| 200-day moving average | $50.46 |
| Wall St. target price | $56.31 |
| PE ratio | 32.6519 |
| Dividend yield | $0.675 (1.28%) |
| Earnings per share (TTM) | $1.35 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $44.08 from 2022-07-01
| 1 week (2022-06-29) | 1.17% |
|---|---|
| 1 month (2022-06-06) | -5.10% |
| 3 months (2022-04-06) | -10.42% |
| 6 months (2022-01-06) | -20.40% |
| 1 year (2021-07-06) | -1.36% |
|---|---|
| 2 years (2020-07-06) | 39.94% |
| 3 years (2019-07-05) | 79.41% |
| 5 years (2017-07-06) | 78.82% |
Valuing Stantec stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Stantec's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Stantec's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 33x. In other words, Stantec shares trade at around 33x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Stantec's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.63. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Stantec's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Stantec's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $430.2 million.
The EBITDA is a measure of a Stantec's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $3.8 billion |
|---|---|
| Operating margin TTM | 8.54% |
| Gross profit TTM | $2 billion |
| Return on assets TTM | 4.26% |
| Return on equity TTM | 9.87% |
| Profit margin | 5.11% |
| Book value | $17.88 |
| Market capitalisation | $4.9 billion |
TTM: trailing 12 months
Dividend payout ratio: 25.63% of net profits
Recently Stantec has paid out, on average, around 25.63% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.28% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Stantec shareholders could enjoy a 1.28% return on their shares, in the form of dividend payments. In Stantec's case, that would currently equate to about $0.675 per share.
While Stantec's payout ratio might seem fairly standard, it's worth remembering that Stantec may be investing much of the rest of its net profits in future growth.
Stantec's most recent dividend payout was on 14 July 2022. The latest dividend was paid out to all shareholders who bought their shares by 28 June 2022 (the "ex-dividend date").
Stantec's shares were split on a 2:1 basis on 16 November 2014. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Stantec shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Stantec shares which in turn could have impacted Stantec's share price.
Over the last 12 months, Stantec's shares have ranged in value from as little as $40.7894 up to $58.0144. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Stantec's is 0.7834. This would suggest that Stantec's shares are less volatile than average (for this exchange).
Stantec Inc. provides engineering, architecture, and environmental consulting services in the areas of infrastructure and facilities in Canada, the United States, and internationally. The company provides consulting services in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics. It also offers structural, mechanical, electrical, plumbing, and hydraulics engineering services; transportation advisory, planning and analytics, transport engineering, and technical design; paleontological and archaeological services for the rail, transportation, water, and power and energy sectors; environmental and infrastructure services; and environmental and cultural resource compliance services. The company was formerly known as Stanley Technology Group Inc. and changed its name to Stantec Inc. in October 1998.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
